Insider Transactions in Q1 2025 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.22%
|
$50,000
$5.02 P/Share
|
|
Mar 05
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.22%
|
$50,000
$5.02 P/Share
|
|
Mar 03
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.44%
|
$40,000
$4.7 P/Share
|
|
Mar 01
2025
|
Timothy Williams SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
26,941
-8.37%
|
$107,764
$4.76 P/Share
|
|
Mar 01
2025
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,941
-7.57%
|
$107,764
$4.76 P/Share
|
|
Mar 01
2025
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
95,999
-4.06%
|
$383,996
$4.76 P/Share
|
|
Mar 01
2025
|
Gunther Birznieks SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
26,941
-6.14%
|
$107,764
$4.76 P/Share
|
|
Mar 01
2025
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,520
-6.09%
|
$62,080
$4.76 P/Share
|
|
Feb 28
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.42%
|
$40,000
$4.76 P/Share
|
|
Feb 27
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.42%
|
$40,000
$4.76 P/Share
|
|
Feb 26
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.21%
|
$40,000
$4.77 P/Share
|
|
Feb 25
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+0.43%
|
$40,000
$4.46 P/Share
|
|
Feb 21
2025
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.56%
|
$8,000
$4.39 P/Share
|
|
Feb 18
2025
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+32.91%
|
-
|
|
Feb 18
2025
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+26.11%
|
-
|
|
Feb 18
2025
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+16.24%
|
-
|
|
Feb 18
2025
|
Timothy Williams SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+27.98%
|
-
|
|
Feb 18
2025
|
Gunther Birznieks SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+22.18%
|
-
|